echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Ann Rheum Dis: Disease activity, cytokines, cogeneration factors, and diabetes risk of rheumatoid arthritis

    Ann Rheum Dis: Disease activity, cytokines, cogeneration factors, and diabetes risk of rheumatoid arthritis

    • Last Update: 2021-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The risk of diabetes (DM) is known to increase in patients with rheumatoid arthritis (RA).
    study aims to determine the association between RA disease activity, including the assessment of specific cytokines and cytokines, and DM.
    were adult RA patients diagnosed by physicians on the Department of Veterans Affairs rheumatoid arthritis registry.
    as part of clinical treatment, the disease activity and clinical evaluation were carried out vertically.
    30 cytokines and coercion factors in the serum were measured when they were entered into the group.
    DM is defined by algorithms that use diagnostic codes and drugs.
    the association between clinical factors and DM incidence using multi-factor Cox proportional risk models.
    the association between cytokines/convergence factors and DM was assessed after adjusting for age, gender, race, smoking, body mass index (BMI) and medication.
    results were as follows: of the 1866 RA patients who did not have DM at the time of joining the group, 9223 patients were followed - after 130 cases had DM.
    disease activity score (DAS28)-C reactive protein (CRP), obesity, age and men are associated with an increased risk of DM, while current smoking and methotrexate use have protective effects.
    who use methotrexate have a lower risk of DM.
    several cytokines/convergence factors were independently associated with DM morbidity, including interletin (IL)-1, IL-6, and macrophage-derived cytokines/convergence factors (HR range 1.11-1.26).
    these associations are not related to DAS28-CRP.
    , it can be seen that in RA patients, high disease activity and increased cytokine/cytokine levels are associated with an increased risk of DM.
    the future, it is possible to study whether targeted treatment of high-risk populations can prevent the occurrence of DM.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.